Suppr超能文献

[三名恶性血液系统疾病患者中的(1;7)(q10;p10)]

[der(1;7) (q10;p10) in three patients with malignant hematologic disorders].

作者信息

Yokoo H, Okada Y, Tominaga K, Tsuji M, Takagi T, Maseki N, Sakurai M, Kaneko Y

机构信息

Department of Clinical Laboratories, Saitama Central Hospital.

出版信息

Rinsho Ketsueki. 1992 Dec;33(12):1829-33.

PMID:1479694
Abstract

The chromosome der(1;7) (q10;p10) is a derivative chromosome consisting of the short arm of chromosome 7 and the long arm of chromosome 1. We observed this abnormality in three patients with acute myeloblastic leukemia (AML), myelodysplastic syndrome (MDS), or myeloproliferative disorder (MPD). Case 1 was a 76-yr-old male with a history of IgG myeloma treated with melphalan, cyclophosphamide, vincristine, and prednisolone (MEVP). AML-M1 developed one and half years after discontinuation of the MEVP therapy. Case 2 was a 39-yr-old male with MDS. Case 3 was a 56-yr-old male with refractory anemia with excess of blasts in transformation that evolved from primary myelofibrosis. Chromosome analyses revealed der(1;7) (q10;p10) in bone marrow cells of the three patients. All patients failed to respond to chemotherapy, and died within four months after the diagnosis. Thus, der (1;7) (q10;p10) may indicate a very poor prognostic outcome in patients with malignant hematologic disorders.

摘要

染色体der(1;7)(q10;p10)是一条由7号染色体短臂和1号染色体长臂组成的衍生染色体。我们在3例急性髓系白血病(AML)、骨髓增生异常综合征(MDS)或骨髓增殖性疾病(MPD)患者中观察到了这种异常。病例1是一名76岁男性,有IgG骨髓瘤病史,曾接受美法仑、环磷酰胺、长春新碱和泼尼松(MEVP)治疗。在停用MEVP治疗一年半后发生了AML-M1。病例2是一名39岁男性,患有MDS。病例3是一名56岁男性,患有转化型原始细胞过多的难治性贫血,由原发性骨髓纤维化演变而来。染色体分析显示3例患者骨髓细胞中存在der(1;7)(q10;p10)。所有患者对化疗均无反应,并在诊断后4个月内死亡。因此,der(1;7)(q10;p10)可能提示恶性血液系统疾病患者的预后非常差。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验